← Back to Search

PennPET Explorer Scanner Evaluation for Body Imaging

N/A

Recruiting

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult participants, at least 18 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year.

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new kind of PET machine that can take pictures of a larger section of the body.

Who is the study for?

This trial is for adults over 18 who can consent to participate or have a representative to do so. It's suitable for those with cognitive impairment and healthy subjects interested in PET imaging research. People with serious health issues, psychological conditions, or mobility problems that could affect their safety or participation are not eligible.

What is being tested?

The study is evaluating the PennPET Explorer Scanner, which is an investigational PET machine capable of imaging larger sections of the body at once compared to current clinical scanners. The goal is to gather data on how best to utilize this whole-body scanner.

What are the potential side effects?

Potential side effects may include reactions related to the radioactive drug used during PET scanning such as discomfort at injection site, allergic reactions, and rare instances of radiation exposure-related risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Image Performance of the LAFOV PennPET Explorer

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: PennPET ExplorerExperimental Treatment1 Intervention

All subjects will be scanned in the CT scanner and then the scanner bed will be moved into position in the PennPET Explorer for initiation of the PET scan. For all PET scans a radioactive imaging drug is used. The radiotracer injection may be performed according to one of the following scenarios: 1. As part of a clinical standard-of-care (SOC) PET/CT or PET/MRI scan (using an FDA-approved radiotracer; the PennPET Explorer cannot yet accommodate a study that requires a commercially available 510(k)-approved instrument for clinical results, subjects in this group will be scanned on both a commercial instrument (PET/CT or PET.MRI) and the PennPET Explorer), 2. As part of another research study (using either an FDA-approved radiotracer or an investigational radiotracer), 3. As a research injection designed specifically to utilize the PennPET Explorer (using an FDA-approved radiotracer).

0 / 1Eligibility criteria met